Exploring Protein-Protein Interactions as Drug Targets for Anti-cancer Therapy with In Silico Workflows
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
We describe a computational protocol to aid the design of small molecule and peptide drugs that target protein-protein interactions, particularly for anti-cancer therapy. To achieve this goal, we explore multiple strategies, including finding binding hot spots, incorporating chemical similarity and bioactivity data, and sampling similar binding sites from homologous protein complexes. We demonstrate how to combine existing interdisciplinary resources with examples of semi-automated workflows. Finally, we discuss several major problems, including the occurrence of drug-resistant mutations, drug promiscuity, and the design of dual-effect inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PubChem Substance and Compound databases
Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv951 · Cited by 5,436
Self-citationYang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1111 · Cited by 4,051
Anatomy of hot spots in protein interfaces
Bogan, A. A., & Thorn, K. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1843 · Cited by 1,988
Shangary, S., & Wang, S. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094723 · Cited by 623
Ma, B., Elkayam, T., Wolfson, H., & Nussinov, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1030237100 · Cited by 595
Interactome3D: adding structural details to protein networks
Mosca, R., Céol, A., & Aloy, P. (2013) · Nature Methods · doi:10.1038/nmeth.2289 · Cited by 479
Zhao, Y., Aguilar, A., Bernard, D., & Wang, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501092z · Cited by 462 · cited 1×
“The success stories include the design of inhibitors of bromo-domains [7], Bax-BclXL [8], p53-MDM2 [9], and VEGF receptor [10].”
BackgroundActivation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization
Graves, B., Thompson, T., Xia, M., Janson, C., Lukacs, C., Deo, D., Di Lello, P., Fry, D., Garvie, C., Huang, K.-S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203789109 · Cited by 230
Predicting the Impact of Missense Mutations on Protein–Protein Binding Affinity
Li, M., Petukh, M., Alexov, E., & Panchenko, A. R. (2014) · Journal of Chemical Theory and Computation · doi:10.1021/ct401022c · Cited by 111
Self-citationBasse, M.-J., Betzi, S., Morelli, X., & Roche, P. (2016) · Database · doi:10.1093/database/baw007 · Cited by 83
Cited by
MutaBind2: predicting the impacts of single and multiple mutations on protein-protein interactions
Zhang, N., Chen, Y., Lu, H., Zhao, F., Alvarez, R. V., Goncearenco, A., Panchenko, A. R., & Li, M. (2020) · iScience · doi:10.1016/j.isci.2020.100939 · Cited by 199
Self-citationAlphaFold, Artificial Intelligence (AI), and Allostery
Nussinov, R., Zhang, M., Liu, Y., & Jang, H. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c04346 · Cited by 190
Artificial intelligence approaches to human-microbiome protein–protein interactions
Lim, H., Cankara, F., Tsai, C.-J., Keskin, O., Nussinov, R., & Gursoy, A. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2022.102328 · Cited by 39
Zheng, F., Jiang, X., Wen, Y., Yang, Y., & Li, M. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.12.018 · Cited by 14
Self-citation
Metadata
- Authors
- Goncearenco, A., Li, M., Simonetti, F. L., Shoemaker, B. A., & Panchenko, A. R.
- Venue
- Methods in Molecular Biology
- Publisher
- Springer New York
- Published
- 2017
- Volume
- 1647
- Pages
- 221-236
- ISSN
- 1064-3745 (ISSN-L)
- 1940-6029
- OpenAlex
- W2748251752
- Cited by
- 41
- References
- 13
- FWCI
- 20.40
- Type
- book chapter
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exploring Protein-Protein Interactions as Drug Targets for Anti-cancer Therapy with In Silico Workflows. https://app.cochat.ai/papers/10.1007/978-1-4939-7201-2_15
- The paper
- Goncearenco, A., Li, M., Simonetti, F. L., Shoemaker, B. A., & Panchenko, A. R. (2017). Exploring Protein-Protein Interactions as Drug Targets for Anti-cancer Therapy with In Silico Workflows. Methods in Molecular Biology. https://doi.org/10.1007/978-1-4939-7201-2_15
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.